This CPB has been revised to state that intravenous iron therapy is considered experimental and investigational for (i) treatment of anemia of inflammation, (ii) prophylactic use of IV iron to improve function in nonanemic persons undergoing hip fracture surgery, and (iii) prophylactic use of IV iron to prevent post-operative anemia in persons undergoing bariatric surgery.